与子宫内膜癌基因型和基因型相关的环境关系
Sanaa Nakad Borrego1, Katherine Kurnit2, Laura Jane Turner3
1Department of Obstetrics & Gynecology, University of Chicago Department of Medicine, Chicago, Illinois, USA.
概括
在子宫内膜癌中,MLH1甲基化与患者的年龄和体重指数有关,这种关系因瘤等级而异. 较高的体重指数与表现出MLH1甲基化的更高度瘤有关.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- MLH1甲基化是子宫内膜癌中常见的分子变异,通常在林奇综合征查期间检测到.
- 基因甲基化模式可以受到各种癌症类型的环境因素的影响,包括营养和衰老.
研究的目的:
- 为了研究衰老,体重指数 (BMI) 和偶发性子宫内膜癌中MLH1甲基化之间的关联.
- 探索这些因素如何影响子宫内膜瘤的分子特征.
主要方法:
- 对子宫内膜癌患者的回顾性审查.
- 使用免疫组织化学检测MLH1表达的林奇综合征查.
- 对具有MLH1损失的瘤进行MLH1甲基化分析.
- 临床信息的抽象,包括年龄和BMI.
主要成果:
- 患有MLH1-甲基化 (不匹配修复缺陷) 瘤的患者年龄大于患有MLH1-富裕瘤的患者.
- MLH1甲基化与更高的淋巴/血管空间入侵发病率有关.
- 在较低级 (1和2) 的子宫内膜瘤中,MLH1甲基化与年龄较大,但与BMI相比较.
- 在更高度 (3) 的子宫内膜瘤中,MLH1甲基化与显著更高的BMI有关,但与年龄没有显著差异.
结论:
- 在子宫内膜癌,年龄和BMI中MLH1甲基化之间的关联是复杂的,并且取决于等级.
- 在具有MLH1甲基化的高度瘤中,BMI较高表明可修改因素在瘤特征中的潜在作用.
更多相关视频
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K


